Return to Newsroom & Events > Get Connected



Makena and Compound 17P

Midwives: We’re talking with other professional societies about the use of Makena to prevent premature birth, and we need your input! Feel free to comment below or e-mail comments to mgreenfield@acnm.org:

  • Do you prescribe synthetic progestin to patients who have a history of preterm birth? 
  • If so, do you prescribe Makena or the generic compound (17P)?*
  • If you prefer 17P over Makena, is it due to cost or an issue of access? 
  • Do you feel safe prescribing 17P?
  • Have you noticed any adverse reactions from Makena or 17P?
  • Do your clients have issues accessing or affording these medications?
  • Have you had any issues with insurance companies when you prescribe these medications? 
  • Is insurance covering Makena? 
  • Have you had patients who need Makena but did not have Medicaid or other insurance and are unable to get Makena? 
  • What are the costs of 17P vs. Makena?

Please share your experience! (Please remember to protect patient privacy by observing HIPAA regulations.)

*17P is not a generic version of Makena. Compounded drugs are not approved or regulated by the FDA.

Posted 9/22/2011 11:11:40 AM
 

 

 



Any opinions expressed in this blog are those of the individual participant(s) and do not necessarily reflect the views of the American College of Nurse-Midwives. ACNM is not responsible for accuracy of any of the information provided by guest bloggers and/or members via the Comments section. We welcome all feedback – including comments, ideas and suggestions. We also welcome civil, friendly debates. However, any and all content that is deemed inflammatory or rude will not be posted.

 

© 2010 American College of Nurse-Midwives. All Rights Reserved. 8403 Colesville Rd, Suite 1550 • Silver Spring MD 20910 • Phone: 240-485-1800 • Fax: 240-485-1818
space